DLTNF logo

Delta 9 Cannabis Inc. (DLTNF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Delta 9 Cannabis Inc. (DLTNF), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 42/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
42/100 AI Puanı

Delta 9 Cannabis Inc. (DLTNF) Sağlık ve Boru Hattı Genel Bakışı

CEOJohn William Arbuthnot IV
Çalışanlar200
MerkezWinnipeg, CA
Halka Arz Yılı2017
SektörHealthcare

Delta 9 Cannabis Inc. is a Canadian integrated cannabis company involved in cultivation, processing, distribution, and retail. With 35 retail stores across the Canadian Prairies, Delta 9 offers a range of cannabis products, including dried flowers, oils, and derivative products, catering to both medical and recreational markets.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Delta 9 Cannabis Inc. presents a speculative investment opportunity in the evolving Canadian cannabis market. The company's integrated business model, encompassing cultivation, processing, distribution, and retail, offers potential for revenue generation across the value chain. However, with a negative profit margin of -24.6% and a negative gross margin of -3.4%, the company's profitability is a concern. Future growth hinges on expanding retail operations, optimizing production costs, and capitalizing on emerging cannabis product trends. Investors should closely monitor the company's ability to achieve profitability and navigate the competitive landscape. The company's P/E ratio is -0.05.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Delta 9 Cannabis Inc. operates as an integrated cannabis company, participating in cultivation, processing, distribution, and retail sales.
  • The company owns and operates 35 retail stores under the Delta 9 brand name across the Canadian Prairies as of April 20, 2022.
  • Delta 9's product portfolio includes dried cannabis flowers, pre-rolls, oils, and extracted products, catering to both medical and recreational markets.
  • The company has a negative profit margin of -24.6% and a negative gross margin of -3.4%, indicating profitability challenges.
  • Delta 9's beta of 1.13 suggests that the stock is more volatile than the market average.

Rakipler & Benzerleri

Güçlü Yönler

  • Integrated operations across the cannabis value chain.
  • Established retail presence in the Canadian Prairies.
  • Proprietary grow pod technology.
  • Delta 9 brand recognition.

Zayıflıklar

  • Negative profit margin and gross margin.
  • Limited geographic presence compared to larger competitors.
  • Reliance on the Canadian cannabis market.
  • Small market capitalization.

Katalizörler

  • Ongoing: Expansion of retail operations to new locations.
  • Ongoing: Development and launch of new cannabis products.
  • Ongoing: Potential changes in cannabis regulations in Canada.
  • Upcoming: Announcement of strategic partnerships or acquisitions.
  • Upcoming: Positive financial results demonstrating improved profitability.

Riskler

  • Ongoing: Intense competition in the Canadian cannabis market.
  • Ongoing: Evolving regulations and compliance requirements.
  • Potential: Fluctuations in cannabis prices affecting revenue.
  • Potential: Economic downturn reducing consumer spending on cannabis.
  • Potential: Delays in regulatory approvals for new products or expansion plans.

Büyüme Fırsatları

  • Expansion of Retail Footprint: Delta 9 can expand its retail presence beyond the Canadian Prairies to other provinces, increasing its market reach and revenue potential. The Canadian cannabis retail market is projected to reach several billion dollars in the coming years, offering significant growth opportunities for companies with established retail networks. The timeline for expansion depends on regulatory approvals and capital availability.
  • Product Innovation and Diversification: Delta 9 can invest in research and development to create new and innovative cannabis products, catering to evolving consumer preferences. This includes developing new formulations, delivery methods, and product formats. The market for cannabis-infused products, such as edibles and beverages, is growing rapidly, presenting opportunities for Delta 9 to diversify its product portfolio. The timeline for product development and launch is typically 12-18 months.
  • Strategic Partnerships and Acquisitions: Delta 9 can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, or research institutions. Acquisitions can provide access to new markets, technologies, or product lines. The timeline for partnerships and acquisitions varies depending on the specific opportunities.
  • International Expansion: Delta 9 can explore opportunities to expand its operations internationally, particularly in countries with legal cannabis markets. This includes exporting cannabis products, establishing joint ventures, or acquiring foreign cannabis companies. The global cannabis market is growing rapidly, offering significant long-term growth potential. The timeline for international expansion depends on regulatory approvals and market conditions.
  • Medical Cannabis Focus: Delta 9 can focus on expanding its medical cannabis business, catering to patients seeking cannabis-based therapies. This includes developing new medical cannabis products, partnering with healthcare providers, and conducting clinical research. The medical cannabis market is growing steadily, driven by increasing awareness of the therapeutic benefits of cannabis. The timeline for medical cannabis initiatives depends on regulatory approvals and clinical trial results.

Fırsatlar

  • Expansion of retail footprint to other provinces.
  • Product innovation and diversification.
  • Strategic partnerships and acquisitions.
  • International expansion.

Tehditler

  • Increasing competition in the Canadian cannabis market.
  • Evolving regulations and compliance requirements.
  • Fluctuations in cannabis prices.
  • Economic downturn affecting consumer spending.

Rekabet Avantajları

  • Integrated operations provide control over the entire value chain.
  • Established retail presence in the Canadian Prairies.
  • Proprietary grow pod technology.
  • Delta 9 brand recognition.

DLTNF Hakkında

Delta 9 Cannabis Inc., incorporated in 2001 and headquartered in Winnipeg, Canada, operates as an integrated cannabis company. Through its subsidiary, Delta 9 Bio-Tech Inc., the company cultivates, processes, extracts, and distributes cannabis products. Delta 9's operations span the entire cannabis value chain, from cultivation to retail sales. The company's product portfolio includes dried cannabis flowers, pre-rolls, decontamination pods, dried sift cannabis, oils, and extracted and derivative products. Delta 9 also provides grow pods and live plants to other licensed and pre-licensed cannabis companies. In addition to its product offerings, Delta 9 operates a medical clinic providing physician consultation services for patients seeking medical cannabis prescriptions. As of April 20, 2022, Delta 9 owned and operated 35 retail stores under the Delta 9 brand name across the Canadian Prairies, solidifying its presence in the regional cannabis market. Delta 9 continues to expand its retail footprint and product offerings to meet the evolving demands of the cannabis market.

Ne Yaparlar

  • Cultivates cannabis plants in controlled environments.
  • Processes raw cannabis into various product forms.
  • Extracts cannabinoids to create oils and concentrates.
  • Wholesales cannabis products to other licensed retailers.
  • Operates retail stores under the Delta 9 brand.
  • Sells medical and recreational cannabis products.
  • Provides physician consultation services for medical cannabis prescriptions.

İş Modeli

  • Vertically integrated operations from cultivation to retail.
  • Revenue generation through wholesale and retail sales of cannabis products.
  • Medical clinic services providing cannabis prescriptions.
  • Sales of grow pods and live plants to other licensed producers.

Sektör Bağlamı

Delta 9 Cannabis Inc. operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing competition, evolving regulations, and shifting consumer preferences. Delta 9 competes with other licensed producers and retailers, vying for market share in both the medical and recreational cannabis segments. The Canadian cannabis market is expected to continue growing, driven by increasing legalization and acceptance of cannabis products. Companies like Delta 9 must adapt to changing regulations and consumer demands to remain competitive.

Kilit Müşteriler

  • Recreational cannabis consumers.
  • Medical cannabis patients with prescriptions.
  • Other licensed cannabis retailers (wholesale).
  • Licensed and pre-licensed cannabis companies (grow pods and live plants).
AI Güveni: 71% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Delta 9 Cannabis Inc. (DLTNF) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

DLTNF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

DLTNF için Wall Street fiyat hedefi analizi.

MoonshotScore

42/100

Bu puan ne anlama geliyor?

MoonshotScore, DLTNF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: John William Arbuthnot IV

CEO

John William Arbuthnot IV serves as the CEO of Delta 9 Cannabis Inc. His leadership is pivotal in guiding the company's strategic direction and operational execution. Information regarding his specific educational background and previous roles is not available. As CEO, he is responsible for overseeing all aspects of the company's operations, including cultivation, processing, distribution, and retail sales. He manages a workforce of approximately 200 employees.

Sicil: Under John William Arbuthnot IV's leadership, Delta 9 Cannabis Inc. has expanded its retail footprint to 35 stores across the Canadian Prairies. He has overseen the development and launch of new cannabis products and the implementation of the company's integrated business model. However, the company's financial performance has been challenged by negative profit margins.

DLTNF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Delta 9 Cannabis Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: As an OTC-listed stock, DLTNF may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. Investors should be aware of the potential for price volatility and illiquidity when trading DLTNF.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Lower trading volumes and liquidity.
  • Potential for price volatility.
  • Higher risk of fraud or manipulation.
  • Limited regulatory oversight.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's regulatory compliance and legal risks.
  • Monitor trading volumes and price movements.
  • Consult with a financial advisor.
  • Understand the risks associated with OTC investing.
Meşruiyet Sinyalleri:
  • Licensed cannabis producer and retailer in Canada.
  • Operational retail stores under the Delta 9 brand.
  • Presence in the cannabis industry since 2001.
  • Integrated operations across the cannabis value chain.

DLTNF Hakkında Sıkça Sorulan Sorular

DLTNF için değerlendirilmesi gereken temel faktörler nelerdir?

Delta 9 Cannabis Inc. (DLTNF) şu anda yapay zeka skoru 42/100, düşük puanı gösteriyor. Temel güçlü yan: Integrated operations across the cannabis value chain.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the Canadian cannabis market.. Bu bir finansal tavsiye değildir.

DLTNF MoonshotScore'u nedir?

DLTNF şu anda MoonshotScore'da 42/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

DLTNF verileri ne sıklıkla güncellenir?

DLTNF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler DLTNF hakkında ne diyor?

DLTNF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

DLTNF'a yatırım yapmanın riskleri nelerdir?

DLTNF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the Canadian cannabis market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

DLTNF'ın P/E oranı nedir?

DLTNF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için DLTNF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

DLTNF aşırı değerli mi, yoksa düşük değerli mi?

Delta 9 Cannabis Inc. (DLTNF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

DLTNF'ın temettü verimi nedir?

Delta 9 Cannabis Inc. (DLTNF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is limited.
  • OTC stocks are inherently riskier than exchange-listed stocks.
Veri Kaynakları

Popüler Hisseler